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Case Report

A 32 year old African American male was admitted to an outside
hospital in July 2007 with symptoms of severe heart failure that
required implantation of a short-term left ventricular assist
device (LVAD). He was subsequently transferred to our facility
due to worsening left ventricular heart failure, episodes of
Torsades de Pointes, and monomorphic ventricular tachycardia.
His device was replaced with a longer-term LVAD and he
was discharged home in October. Fortunately, he underwent
successful orthotopic heart transplant in November 2007.
Surgical pathology of the explanted heart revealed widespread
cardiomyocyte necrosis, marked polymorphous inflammation,
and giant cell formation consistent with idiopathic giant cell
myocarditis (figures). Follow-up post transplant endomyocardial
biopsies did not reveal recurrence of giant cell myocarditis or
acute rejection.
Figure 2. Low power image (40x, H&E) showing clear delineation
of involved areas with inflammatory cell infiltration, giant cells, and
myocyte damage compared to relatively unaffected myocardium on
the left.

Figure 3. High power image (400x, H&E) showing a mixed
inflammatory cell infiltrate composed of eosinophils, plasma cells,
small lymphocytes, and multinucleated giant cells. Prototypical
multinucleated giant cell indicated by large thick arrow. Thinner
arrow shows associated myocyte damage.

Discussion

Figure 1. Gross image of left ventricular myocardium showing nodular, ovoid
tan-white areas (indicated by arrows) that microscopically corresponded to
the areas of inflammatory cell infiltration and myocyte necrosis.

Idiopathic Giant Cell Myocarditis (IGCM) is a rare and generally
fatal entity that has been largely confined to scattered case reports
and observational studies, most notably a multi-center registry
created by Cooper et al in 1997. While IGCM has historically
been a histological diagnosis at autopsy, the current gold standard
method of diagnosis remains endomyocardial biopsy. This

29

disorder typically afflicts younger adults with mean age of fortythree.2 It is most commonly characterized by rapid and progressive
congestive heart failure generally refractory to conventional heart
failure treatments. Other common clinical presentations include
ventricular arrhythmias, heart block, and less commonly as early
symptoms of acute myocardial infarction.
While no uniform guidelines yet exist for the treatment of IGCM,
animal models suggest involvement of CD4 T-lymphocytes5,9
with reported success with combined steroid and immunosuppressive therapy.2,3,7 Reported associations with autoimmune
disorders are also consistent with this theory.1,6
Patients in the IGCM registry that received immunosuppression lived longer than those that did not.2 Heart transplantation also appeared to be efficacious with 5-year survival data
reported at 71% despite recurrence of disease in 20-42% of the
newly transplanted hearts.2,4,8 Our case of IGCM illustrates the
importance of surveillance biopsies and the growing evidence
that transplantation and immunosuppression may be effective
therapy for an otherwise rapidly fatal disease.
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